Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women

B Siegerink1,2,3, A Maino1,4, A Algra1,5,6

  • 1Department Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.

Insights

Prothrombotic factors, indicators of hypercoagulability, are more strongly linked to ischemic stroke (IS) risk than myocardial infarction (MI) risk in young women. This suggests distinct hypercoagulability roles in the development of these arterial thrombotic events.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Thrombosis Research

Background:

  • Myocardial infarction (MI) and ischemic stroke (IS) are acute arterial thrombotic events with partially overlapping risk factors.
  • Distinct pathophysiological mechanisms underlie MI and IS, necessitating investigation into differential risk factor associations.

Purpose of the Study:

  • To investigate whether hypercoagulability differentially impacts the risk of MI versus IS.
  • To identify specific prothrombotic factors associated with increased risk for either MI or IS.

Main Methods:

  • Analysis of a population-based case-control study (Risk of Arterial Thrombosis in Relation to Oral Contraceptives) involving young women (<50 years).
  • Comparison of relative odds ratios (ORIS/ORMI) and confidence intervals for 29 identified prothrombotic factors in women with MI, non-cardioembolic IS, and healthy controls.

Main Results:

  • Seventy-two percent (21/29) of hypercoagulability measures showed increased odds ratios for arterial thrombosis.
  • Twelve factors (41%) demonstrated odds ratios greater than 2, and five factors (17%) exceeded 2.75.
  • Activated factor XI (FXI) and FXII, kallikrein, lupus anticoagulans, and FXIII gene variation showed the most significant differential associations.

Conclusions:

  • Prothrombotic factors are more strongly associated with ischemic stroke risk than myocardial infarction risk in young women.
  • These findings suggest a differential role of hypercoagulability in the pathogenesis of IS compared to MI.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.8K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
861
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
763
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
697